Papp-A As A Screening Tool for Assessment of Gestational Age Before Medication Abortion in An Intended-Use Population
Biomarkers in Medicine · 2023
DOI: 10.2217/bmm-2022-0653 ↗At a glance
Journal article in Biomarkers in Medicine, 2023. Written by Laura J Frye and 4 co-authors. Institution: Gynuity Health Projects, 220 East 42nd Street New York, NY 10017, USA. Major MEDLINE topics: Pregnancy-Associated Plasma Protein-A, Abortion, Induced. Cited 1 times so far (Crossref); 23 references. The full text is freely available in PubMed Central. Funded by: NCATS NIH HHS, Anonymous donor.
Abstract (original language)
Introduction
Prior studies indicate that PAPP-A could serve as a marker of gestational age (GA) with the potential to determine eligibility for medication abortion. The authors validated the relationship between PAPP-A and GA in an actual-use population. Materials & methods: The authors collected blood samples, medical histories and ultrasound-determined GA from patients presenting for abortion services. They measured PAPP-A using two immunoassays and assessed diagnostic accuracy for predicting GA ≥71 days.
Results
The Ansh Labs and R&D Systems immunoassays produced an area under the ROC curve of 0.982 (95% CI: 0.958-0.994) and 0.986 (95% CI: 0.963-0.996), respectively, for predicting GA ≥71 days.
Conclusion
This validation study in an intended-use population confirmed that PAPP-A has a strong ability to distinguish pregnancies above and below 71 days' gestation. Clinical trial registration: NCT04232189 (ClinicalTrials.gov). In the USA, abortion with pills is an option for people with pregnancies of less than 71 days. Usually, people use ultrasound to find out how far along a pregnancy is. Ultrasound can be pricey and hard to find. Some studies show that a protein in blood, called PAPP-A, may be another option. The authors took blood from and did ultrasounds for people who wanted an abortion. They measured how much PAPP-A was in the blood using two different methods. The level of PAPP-A in the blood did a good job of distinguishing pregnancies that were higher and lower than 71 days.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Gynuity Health Projects, 220 East 42nd Street New York, NY 10017, USA.
- Department of Obstetrics & Gynecology, University of Illinois at Chicago College of Medicine, Chicago, IL 60612, USA.
ORCID profiles: Laura J Frye
Funding
- NCATS NIH HHS
- Anonymous donor
Cite
APA
Frye, L. J., Buhimschi, I. A., Raymond, E. G., Zhao, G., & Winikoff, B. (2023). Papp-A As A Screening Tool for Assessment of Gestational Age Before Medication Abortion in An Intended-Use Population. Biomarkers in Medicine. https://doi.org/10.2217/bmm-2022-0653
Vancouver
Frye LJ, Buhimschi IA, Raymond EG, Zhao G, Winikoff B. Papp-A As A Screening Tool for Assessment of Gestational Age Before Medication Abortion in An Intended-Use Population. Biomarkers in Medicine. 2023. doi:10.2217/bmm-2022-0653
BibTeX
@article{Frye2023,
author = {Frye, Laura J and Buhimschi, Irina A and Raymond, Elizabeth G and Zhao, Guomao and Winikoff, Beverly},
title = {Papp-A As A Screening Tool for Assessment of Gestational Age Before Medication Abortion in An Intended-Use Population},
journal = {Biomarkers in Medicine},
year = {2023},
doi = {10.2217/bmm-2022-0653}
}
EUVIMED